ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 78 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 2,274 | -38.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 3,667 | +273.8% | 0.00% | – |
| Q1 2022 | $2,000 | -94.1% | 981 | -90.4% | 0.00% | – |
| Q2 2020 | $34,000 | +240.0% | 10,210 | +413.3% | 0.00% | – |
| Q1 2019 | $10,000 | 0.0% | 1,989 | -43.5% | 0.00% | – |
| Q4 2018 | $10,000 | -78.3% | 3,519 | -38.7% | 0.00% | – |
| Q3 2018 | $46,000 | +70.4% | 5,742 | +78.2% | 0.00% | -100.0% |
| Q1 2018 | $27,000 | +285.7% | 3,222 | +471.3% | 0.00% | – |
| Q4 2017 | $7,000 | -72.0% | 564 | -81.4% | 0.00% | -100.0% |
| Q3 2017 | $25,000 | -86.8% | 3,029 | -72.9% | 0.00% | -87.5% |
| Q2 2017 | $189,000 | -59.5% | 11,196 | -51.9% | 0.01% | -60.0% |
| Q1 2017 | $467,000 | +436.8% | 23,260 | +312.6% | 0.02% | +300.0% |
| Q4 2016 | $87,000 | – | 5,638 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |